Association of CYP2D6 and CYP2C19 metabolizer status with switching and discontinuing antidepressant drugs: an exploratory study
Sign Up to like & getrecommendations! Published in 2024 at "BMC Psychiatry"
DOI: 10.1186/s12888-024-05764-6
Abstract: Tailoring antidepressant drugs (AD) to patients’ genetic drug-metabolism profile is promising. However, literature regarding associations of ADs’ treatment effect and/or side effects with drug metabolizing genes CYP2D6 and CYP2C19 has yielded inconsistent results. Therefore, our… read more here.
Keywords: metabolizer status; cyp2c19; status switching; metabolizer ... See more keywords